Recurrent and founder mutations in the Netherlands Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation

被引:10
|
作者
Aalberts, J. J. J. [2 ]
Schuurman, A. G. [1 ]
Pals, G. [3 ]
Hamel, B. J. C. [4 ]
Bosman, G. [1 ]
Hilhorst-Hofstee, Y. [5 ]
Barge-Schaapveld, D. Q. C. M. [6 ]
Mulder, B. J. M. [7 ]
van den Berg, M. P. [2 ]
van Tintelen, J. P. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Ctr Thorax, NL-9700 RB Groningen, Netherlands
[3] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands
[5] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[6] Univ Amsterdam, Dept Clin Genet, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[7] Univ Amsterdam, Dept Cardiol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
关键词
Marfan Syndrome/genetics; Microfilament Proteins; Mutation; Missense; Netherlands; TGF-BETA ACTIVATION; 1009; PROBANDS; MOUSE MODEL; GENE; FIBRILLINOPATHIES; PATHOGENESIS; DISORDERS;
D O I
10.1007/BF03091743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Methods. Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene. Typical characteristics of MPS that have been described include dolichostenomelia, ectopia lentis and aortic root dilatation. However, there is great clinical variability in the expression of the syndrome's manifestations, both between and within families. Here we discuss the clinical variability of MFS by describing a large four-generation Dutch family with MFS. Results. Nineteen individuals of one family with a single missense FBN1 mutation (c.7916A>G) were identified. The same mutation was found in one unrelated person. Clinical variability was extensive and not all mutation carriers fulfilled the diagnostic criteria for MFS. Some patients only expressed mild skeletal abnormalities, whereas aortic root dilation was present in eight patients, an acute type A aortic dissection was recorded in two other patients, and a mitral valve prolapse was present in eight patients. In some patients cardiac features were not present on initial screening, but did however develop over time. Conclusion. MFS is a clinically highly variable syndrome, which means a meticulous evaluation of suspected cases is crucial. Mutation carriers should be re-evaluated regularly as cardiovascular symptoms may develop over time. (Neth Heart J 2010;18:85-9.)
引用
收藏
页码:85 / 89
页数:5
相关论文
共 50 条
  • [1] Recurrent and founder mutations in the NetherlandsExtensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation
    J. J. J. Aalberts
    A. G. Schuurman
    G. Pals
    B. J. C. Hamel
    G. Bosman
    Y. Hilhorst-Hofstee
    D. Q. C. M. Barge-Schaapveld
    B. J. M. Mulder
    M. P. van den Berg
    J. P. van Tintelen
    Netherlands Heart Journal, 2010, 18 : 85 - 89
  • [2] A recurrent fibrillin-1 mutation in severe early onset Marfan syndrome
    Sureka, Dimple
    Stheneur, Chantal
    Odent, Sylvie
    Arno, Gavin
    Murphy, Daniel
    Bernstein, Jonathan A.
    JOURNAL OF PEDIATRIC GENETICS, 2014, 3 (03) : 157 - 162
  • [3] Missense mutations of the fibrillin-1 gene in two Chinese patients with severe Marfan syndrome
    Ivan F.M. LO
    Rosanna M.S. WONG
    Fanny W.F. LAM
    Tony M.F. TONG and Stephen T.S. LAM
    ChineseMedicalJournal, 2001, (05)
  • [4] Missense mutations of the fibrillin-1 gene in two Chinese patients with severe Marfan syndrome
    Lo, IFM
    Wong, RMS
    Lam, FWF
    Tong, TMF
    Lam, STS
    CHINESE MEDICAL JOURNAL, 2001, 114 (05) : 473 - 476
  • [6] MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE
    DIETZ, HC
    CUTTING, GR
    PYERITZ, RE
    MASLEN, CL
    SAKAI, LY
    CORSON, GM
    PUFFENBERGER, EG
    HAMOSH, A
    NANTHAKUMAR, EJ
    CURRISTIN, SM
    STETTEN, G
    MEYERS, DA
    FRANCOMANO, CA
    NATURE, 1991, 352 (6333) : 337 - 339
  • [7] Six novel mutations of the fibrillin-1 gene in Korean patients with Marfan syndrome
    Oh, MR
    Kim, JS
    Beck, NS
    Lee, HJ
    Kohsaka, T
    Jin, DK
    PEDIATRICS INTERNATIONAL, 2000, 42 (05) : 488 - 491
  • [8] Recurrent spontaneous coronary dissections in a patient with a de novo fibrillin-1 mutation without Marfan syndrome
    von Hundelshausen, Philipp
    Oexle, Konrad
    Bidzhekov, Kiril
    Schmitt, Martin M.
    Hristov, Michael
    Blanchet, Xavier
    Kaemmerer, Harald
    Matyas, Gabor
    Meitinger, Thomas
    Weber, Christian
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (03) : 668 - 670
  • [9] Novel frameshift mutations in fibrillin-1 gene causing Marfan syndrome
    Gusina, A.
    Miasnikov, S.
    Gusina, N.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 914 - 914
  • [10] A novel mutation of the fibrillin-1 gene in a newborn with severe Marfan syndrome
    Kochilas, L.
    Gundogan, F.
    Atalay, M.
    Bliss, J. M.
    Vatta, M.
    Pena, L. S.
    Abuelo, D.
    JOURNAL OF PERINATOLOGY, 2008, 28 (04) : 303 - 305